Kojin Therapeutics

View the org chart displaying its 13 main executives

Most searched biographies at Kojin Therapeutics

• Harvey Berger, Chairman of the Board, President and Chief Executiv...
• Stuart Schreiber, Director
• Gini Deshpande, Board Member

Popular executive movements at Kojin Therapeutics

• Harvey Berger has joined the company as Chairman of the Board, President and Chief Executive Officer  (posted on January 3 2024).

Create your alert
to follow the executive moves at Kojin Therapeutics.

Kojin Therapeutics has 2,298 competitors including Lonza (Switzerland), Eurofins (Luxembourg) and Adaptive Phage Therapeutics (United States (USA)).

Popular M&A news in Biotechnology

• AltruBio has just announced a $225 Million fundraising (posted on May 24 2024).
• Genmab has acquired ProfoundBio (posted on May 23 2024).
• Centivo has announced the acquisition of Eden Health  (posted on May 23 2024).

Popular contacts in Biotechnology

• Ali Behbahani - Non-Executive Director at Adaptimmune Therapeutics
• Carl Gordon - Director at Adicet Bio
• Khalil Barrage - Interim Chairman of the Board at Sensorion

Learn more about the Biotechnology industry >

Press releases by Kojin Therapeutics

Social media about Kojin Therapeutics

• Kojin Therapeutics on Wikipedia, Google News & Yahoo Finance
• Kojin Therapeutics on LinkedIn, Twitter & YouTube

Contact by email its executives including Harvey Berger

Call Kojin Therapeutics at +1 855...

View the org chart

Register to receive your alert

Report an error